Angiotensin-I-converting enzyme DD genotype is a risk factor of coronary artery disease

被引:22
作者
Sigusch, HH [1 ]
Vogt, S [1 ]
Gruber, U [1 ]
Reinhardt, D [1 ]
Lang, K [1 ]
Surber, R [1 ]
Farker, K [1 ]
Muller, S [1 ]
Hoffmann, A [1 ]
机构
[1] UNIV JENA,INST CLIN PHARMACOL,D-07740 JENA,GERMANY
关键词
angiotensin-converting enzyme; coronary artery disease; polymerase chain reaction; polymorphism; risk factors;
D O I
10.1080/00365519709056380
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Coronary artery disease (CAD) is a polygenic disease whose phenotypic manifestation depends on the interaction of a number of environmental factors. A number of genes, including the angiotensin-I-converting enzyme (ACE) gene, have been implicated in the pathogenesis of CAD. ACE could affect smooth muscle cell and fibroblast migration and proliferation, low-density lipoprotein (LDL) oxidation and endothelial cell function; these are all important factors in atherosclerosis. A polymorphic variant of the ACE gene correlates with higher circulating ACE levels and carries an increased risk of myocardial infarction, and cardiomyopathies. In this study, we sought to determine the distribution of ACE genotypes and the frequency of allele D in patients undergoing coronary angiography at our institution. DNA from 196 patients with angiographically proven CAD and 96 controls without CAD was amplified by polymerase chain reaction (PCR). The primers flanked the region of the ACE gene (intron 16) where the insertion (I) or deletion (D) of a 287-bp fragment results in the I/D polymorphism. PCR amplification of alleles I and D resulted in 490- and 190-bp products, respectively. In the control group, the relative allele frequencies of the poly morphism were similar to those of previously published European studies. The ACE genotype DD was present in 37.3% of patients with CAD as compared to 23.4% in the controls (p<0.003., odds ratio 1.95, 95% confidence intervals (CI) 1.06-3.57). There was no association with the history of prior myocardial infarction. The genotype distribution in patients with single-vessel involvement was not significantly different from controls (p = 0.14). However, the DD genotype was significantly more common in patients having multivessel CAD when compared to single-vessel disease, indicating an association of this polymorphism with the extent of CAD. ACE genotype DD is more common in patients with multivessel CAD as compared to controls and to patients with single-vessel involvement, indicating that genotype DD is a genetic risk factor for extensive, multivessel CAD.
引用
收藏
页码:127 / 132
页数:6
相关论文
共 27 条
  • [1] PLASMA-LEVEL AND GENE POLYMORPHISM OF ANGIOTENSIN-CONVERTING ENZYME IN RELATION TO MYOCARDIAL-INFARCTION
    CAMBIEN, F
    COSTEROUSSE, O
    TIRET, L
    POIRIER, O
    LECERF, L
    GONZALES, MF
    EVANS, A
    ARVEILER, D
    CAMBOU, JP
    LUC, G
    RAKOTOVAO, R
    DUCIMETIERE, P
    SOUBRIER, F
    ALHENC-GELAS, F
    [J]. CIRCULATION, 1994, 90 (02) : 669 - 676
  • [2] DELETION POLYMORPHISM IN THE GENE FOR ANGIOTENSIN-CONVERTING ENZYME IS A POTENT RISK FACTOR FOR MYOCARDIAL-INFARCTION
    CAMBIEN, F
    POIRIER, O
    LECERF, L
    EVANS, A
    CAMBOU, JP
    ARVEILER, D
    LUC, G
    BARD, JM
    BARA, L
    RICARD, S
    TIRET, L
    AMOUYEL, P
    ALHENCGELAS, F
    SOUBRIER, F
    [J]. NATURE, 1992, 359 (6396) : 641 - 644
  • [3] A COMPARISON OF ENALAPRIL WITH HYDRALAZINE ISOSORBIDE DINITRATE IN THE TREATMENT OF CHRONIC CONGESTIVE-HEART-FAILURE
    COHN, JN
    JOHNSON, G
    ZIESCHE, S
    COBB, F
    FRANCIS, G
    TRISTANI, F
    SMITH, R
    DUNKMAN, WB
    LOEB, H
    WONG, ML
    BHAT, G
    GOLDMAN, S
    FLETCHER, RD
    DOHERTY, J
    HUGHES, CV
    CARSON, P
    CINTRON, G
    SHABETAI, R
    HAAKENSON, C
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (05) : 303 - 310
  • [4] *CONSENSUS TRIAL S, 1987, NEW ENGL J MED, V316, P1429
  • [5] A DELETION POLYMORPHISM IN THE ANGIOTENSIN-CONVERTING ENZYME GENE IS NOT ASSOCIATED WITH CORONARY HEART-DISEASE IN AN AUSTRIAN POPULATION
    FRIEDL, W
    KREMPLER, F
    PAULWEBER, B
    PICHLER, M
    SANDHOFER, F
    [J]. ATHEROSCLEROSIS, 1995, 112 (02) : 137 - 143
  • [6] GENE POLYMORPHISM BUT NOT CATALYTIC ACTIVITY OF ANGIOTENSIN I-CONVERTING ENZYME IS ASSOCIATED WITH CORONARY-ARTERY DISEASE AND MYOCARDIAL-INFARCTION IN LOW-RISK PATIENTS
    GARDEMANN, A
    WEISS, T
    SCHWARTZ, O
    EBERBACH, A
    KATZ, N
    HEHRLEIN, FW
    TILLMANNS, H
    WAAS, W
    HABERBOSCH, W
    [J]. CIRCULATION, 1995, 92 (10) : 2796 - 2799
  • [7] CARDIOPROTECTIVE POTENTIAL OF ANGIOTENSIN CONVERTING ENZYME-INHIBITORS
    GAVRAS, H
    GAVRAS, I
    [J]. JOURNAL OF HYPERTENSION, 1991, 9 (05) : 385 - 392
  • [8] ASSOCIATION ANALYSIS OF A POLYMORPHISM OF THE ANGIOTENSIN CONVERTING ENZYME GENE WITH ESSENTIAL-HYPERTENSION IN THE JAPANESE POPULATION
    HIGASHIMORI, K
    ZHAO, Y
    HIGAKI, J
    KAMITANI, A
    KATSUYA, T
    NAKURA, J
    MIKI, T
    MIKAMI, H
    OGIHARA, T
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 191 (02) : 399 - 404
  • [9] TISSUE-SPECIFIC ACTIVATION OF CARDIAC ANGIOTENSIN CONVERTING ENZYME IN EXPERIMENTAL HEART-FAILURE
    HIRSCH, AT
    TALSNESS, CE
    SCHUNKERT, H
    PAUL, M
    DZAU, VJ
    [J]. CIRCULATION RESEARCH, 1991, 69 (02) : 475 - 482
  • [10] TISSUE ANGIOTENSIN-CONVERTING ENZYME IN CARDIAC AND VASCULAR HYPERTROPHY, REPAIR, AND REMODELING
    JOHNSTON, CI
    [J]. HYPERTENSION, 1994, 23 (02) : 258 - 268